Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the...

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Acute colitis can be induced in mice using trinitrobenzene sulfonic acid (TNBS).
• Inflammatory bowel disease (IBD) models are crucial for developing new therapeutic strategies.
• Yersinia species possess components with potential anti-inflammatory properties.

Purpose of the Study:

• To evaluate the efficacy of virulence-attenuated Yersinia pseudotuberculosis in preventing TNBS-induced colitis.
• To investigate the anti-inflammatory effects of specific Yersinia components in a murine colitis model.

Main Methods:

• Mice were orally inoculated with a phoP mutant of Yersinia pseudotuberculosis.
• Acute colitis was induced via rectal instillation of TNBS.
• Colonic tissues were analyzed for lesions and tumor necrosis factor alpha (TNF-α) mRNA levels.

Main Results:

• Oral administration of attenuated Yersinia pseudotuberculosis significantly reduced colonic lesions in TNBS-treated mice.
• Tumor necrosis factor alpha mRNA levels were significantly decreased in the colons of mice treated with Yersinia.
• The phoP mutant of Yersinia pseudotuberculosis demonstrated protective effects against acute colitis.

Conclusions:

• Virulence-attenuated Yersinia pseudotuberculosis exhibits significant anti-inflammatory effects in a mouse model of colitis.
• Yersinia-derived anti-inflammatory components hold promise for the development of novel therapeutics for inflammatory bowel disease.
• This study highlights a potential probiotic or therapeutic approach using attenuated Yersinia for managing colitis.